Edaravone Inhibits the Production of Reactive Oxygen Species in Phagocytosis- and PKC-Stimulated Granulocytes from Multiple Sclerosis Patients Edaravone Modulate Oxidative Stress in Multiple Sclerosis
Open Access
- 1 April 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Central Nervous System Disease
- Vol. 14
Abstract
Background: Oxidative stress is associated with the pathogenesis of MS. Edaravone (EDV) has been proposed as a therapeutic resource for central nervous system diseases, and it was effective in reducing oxidative stress. However, the antioxidant mechanisms of EDV are poorly studied. Objective: This study aimed to evaluate the effects of EDV on resting, phagocytosis, and PKC-activated granulocytes derived from MS patients and a healthy control group. Methods: The effects of EDV on ROS production in phagocytosis (ROS production in the presence of opsonized particles) and PKC-stimulated granulocytes were evaluated in a luminol-dependent chemiluminescence method. Calphostin C was used in some experiments to compare with those of EDV. Results: EDV inhibited ROS production in phagocytosis of opsonized particles and PKC-stimulated granulocytes from MS patients and healthy control group. In the presence of calphostin C, the inhibition of ROS production was similar to that observed with EDV. Conclusion: These findings suggest the involvement of EDV on the ROS-PKC-NOX signaling pathways modulating oxidative stress in MS. EDV represents a promising treatment option to control oxidative innate immune response for MS.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
This publication has 69 references indexed in Scilit:
- NADPH oxidases: novel therapeutic targets for neurodegenerative diseasesTrends in Pharmacological Sciences, 2012
- NADPH oxidase in stroke and cerebrovascular diseaseNeurological Research, 2012
- Oxidative damage in multiple sclerosis lesionsBrain, 2011
- NADPH Oxidase 2-Derived Reactive Oxygen Species Mediate FFAs-Induced Dysfunction and Apoptosis of β-Cells via JNK, p38 MAPK and p53 PathwaysPLOS ONE, 2010
- Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitroBrain Research, 2010
- Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischaemia‐reperfusionJournal of Cellular and Molecular Medicine, 2008
- Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neuronsBMC Neuroscience, 2008
- Nitric oxide‐induced apoptosis in cultured rat astrocytes: Protection by edaravone, a radical scavengerGlia, 2007
- Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patientsNeurochemistry International, 2006
- Rating neurologic impairment in multiple sclerosisNeurology, 1983